Auteurs
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration MERS - Corpus (PubMed)

Index « Auteurs » - entrée « Christopher M. Coleman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Christopher L. Warren < Christopher M. Coleman < Christopher M. Dobson  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000413 (2019) Kirsten A. Kulcsar ; Christopher M. Coleman ; Sarah E. Beck ; Matthew B. FriemanComorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.
000D66 (2017) Christopher M. Coleman ; Thiagarajan Venkataraman ; Ye V. Liu ; Gregory M. Glenn ; Gale E. Smith ; David C. Flyer ; Matthew B. FriemanMERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
000F08 (2017) Christoph Wirblich ; Christopher M. Coleman ; Drishya Kurup ; Tara S. Abraham ; John G. Bernbaum ; Peter B. Jahrling ; Lisa E. Hensley ; Reed F. Johnson ; Matthew B. Frieman ; Matthias J. SchnellOne-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.
000F13 (2017) Christopher M. Coleman ; Jeanne M. Sisk ; Gabor Halasz ; Jixin Zhong ; Sarah E. Beck ; Krystal L. Matthews ; Thiagarajan Venkataraman ; Sanjay Rajagopalan ; Christos A. Kyratsous ; Matthew B. FriemanCD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.
001022 (2016) Christopher M. Coleman ; Jeanne M. Sisk ; Rebecca M. Mingo ; Elizabeth A. Nelson ; Judith M. White ; Matthew B. FriemanAbelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
001257 (2016) Thomas Luke ; Hua Wu ; Jincun Zhao ; Rudragouda Channappanavar ; Christopher M. Coleman ; Jin-An Jiao ; Hiroaki Matsushita ; Ye Liu ; Elena N. Postnikova ; Britini L. Ork ; Gregory Glenn ; David Flyer ; Gabriel Defang ; Kanakatte Raviprakash ; Tadeusz Kochel ; Jonathan Wang ; Wensheng Nie ; Gale Smith ; Lisa E. Hensley ; Gene G. Olinger ; Jens H. Kuhn ; Michael R. Holbrook ; Reed F. Johnson ; Stanley Perlman ; Eddie Sullivan ; Matthew B. FriemanHuman polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
001478 (2015) Christopher M. Coleman ; Matthew B. FriemanGrowth and Quantification of MERS-CoV Infection.
001572 (2015) Kristen E. Pascal ; Christopher M. Coleman ; Alejandro O. Mujica ; Vishal Kamat ; Ashok Badithe ; Jeanette Fairhurst ; Charleen Hunt ; John Strein ; Alexander Berrebi ; Jeanne M. Sisk ; Krystal L. Matthews ; Robert Babb ; Gang Chen ; Ka-Man V. Lai ; Tammy T. Huang ; William Olson ; George D. Yancopoulos ; Neil Stahl ; Matthew B. Frieman ; Christos A. KyratsousPre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.
001827 (2014) Christopher M. Coleman ; Matthew B. FriemanTreating MERS-CoV during an outbreak.
001976 (2014) Julie Dyall ; Christopher M. Coleman ; Brit J. Hart ; Thiagarajan Venkataraman ; Michael R. Holbrook ; Jason Kindrachuk ; Reed F. Johnson ; Gene G. Olinger ; Peter B. Jahrling ; Monique Laidlaw ; Lisa M. Johansen ; Calli M. Lear-Rooney ; Pamela J. Glass ; Lisa E. Hensley ; Matthew B. FriemanRepurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
001978 (2014) Adeyemi O. Adedeji ; Kamalendra Singh ; Ademola Kassim ; Christopher M. Coleman ; Ruth Elliott ; Susan R. Weiss ; Matthew B. Frieman ; Stefan G. SarafianosEvaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
001A07 (2014) Christopher M. Coleman ; Ye V. Liu ; Haiyan Mu ; Justin K. Taylor ; Michael Massare ; David C. Flyer ; Gale E. Smith ; Matthew B. FriemanPurified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.
001A34 (2014) Christopher M. Coleman ; Matthew B. FriemanCoronaviruses: important emerging human pathogens.
001A88 (2014) Krystal L. Matthews ; Christopher M. Coleman ; Yvonne Van Der Meer ; Eric J. Snijder ; Matthew B. FriemanThe ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling.
001B49 (2014) Christopher M. Coleman ; Krystal L. Matthews ; Lindsay Goicochea ; Matthew B. FriemanWild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i -k "Christopher M. Coleman" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i  \
                -Sk "Christopher M. Coleman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Christopher M. Coleman
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021